TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Roche Diagnostics Norge AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
214,254
|
137,616
|
61,160 |
Financial expenses |
125
|
70
|
102 |
Earnings before taxes |
9,987
|
2,135
|
2,380 |
Total assets |
34,454
|
65,529
|
32,626 |
Current assets |
29,980
|
64,082
|
30,815 |
Current liabilities |
25,503
|
54,227
|
23,444 |
Equity capital |
8,952
|
11,302
|
9,183 |
- share capital |
555
|
586
|
555 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
26.0%
|
17.2%
|
28.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.7%
|
1.6%
|
3.9% |
Return on assets (ROA) |
29.3%
|
3.4%
|
7.6% |
Current ratio |
117.6%
|
118.2%
|
131.4% |
Return on equity (ROE) |
111.6%
|
18.9%
|
25.9% |
Change turnover |
83,866
|
73,134
|
10,052 |
Change turnover % |
64%
|
113%
|
20% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.